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Background Bacterial pleural infection has been a substantial clinical challenge since ancient times. It is a major cause of morbidity and mortality, and its incidence continues to rise both in adults and children 1, 2, 3 .
About 40% of all patients with pneumonia will have an associated pleural effusion, although a minority will require an intervention for a complicated parapneumonic effusion or empyema 4, 5 . Delay in diagnosis, failure to institute appropriate antimicrobial therapy, and inadequate drainage of pleural space contribute to increased morbidity and mortality in these patients 3 .
Prompt evaluation and therapeutic intervention appears to reduce morbidity and mortality as well as healthcare costs associated with pleural infection 3 . Pleural fluid characteristics remain the most reliable diagnostic test to guide management 1, 6 . Identification of the infecting bacteria by culture of pleural fluid is of great importance for clinical care. Pleural fluid culture also provides the sensitivity profile of the isolated microorganism to various antibiotics. This will help the clinician for proper antibiotic selection. Conventional pleural fluid cultures, especially in the event of the prior use of antibiotics, exhibit a low sensitivity. About 40% of cases has a negative culture results 2 . These patients are treated with empirical antibiotics that cover the spectrum of likely pathogens, resulting in polypharmacy and its associated disadvantages. Anaerobic antibiotic treatment is frequently given empirically, as anaerobes are often implicated in empyema although their pick-up rates by standard laboratory cultures are poor 7 . Peripheral blood culture can increase the identification rate of the causative organism, while sputum cultures are positive less often than pleural fluid cultures 8, 9 . Inoculating pleural fluid into blood culture bottles at the bedside can probably improve the yield of pleural fluid culture 10, 11 . Several studies of this approach suggest clinically significant higher bacterial isolate rates [12] [13] [14] [15] [16] . In other clinical settings, inoculation of various other fluids like peritoneal dialysate 14, 17 , peritoneal fluid 18 and synovial fluid 14, 19 into blood culture bottles has been shown to be clinically useful. This study assesses whether inoculating pleural fluid into blood culture bottle identifies more bacteria than standard laboratory culture in the evaluation of empyema. Figure 1 The value of adding blood culture bottle culture methods to standard culture in detection of pathogen Together with these two studies the current study results show that blood culture bottle culture is a valuable adjunct to standard laboratory plated culture in empyema and should be part of standard care. It is very interesting that this finding is similar to the results in other 'nonblood' uses of blood culture bottle culture. In bacterial peritonitis, peritoneal fluid culture in blood culture bottle increased the bacterial isolation rate by 29-49% 18 , from a positivity rate on standard culture of 42-54%. In synovial fluid culture, blood culture bottle culture increased the bacterial isolation rate by about 20% over the 10-20% culture positivity with standard culture 14, 19 .
Materials and Methods
This study used repeated standard laboratory culture as a control intervention to test whether the improved yield of organisms using blood culture bottles was simply due to repeating the culture process. But second standard culture didn't produce any increase in bacterial yield. Hence blood culture bottle culture is superior to simple repetition of standard culture. 
Limitations of the Study
There were several potential limitations to this study. Firstly, this was not a blinded study, which could have lead to several bias in identifying bacteria during culture. In addition, anaerobic culture was not done. Different bacteria may have preferential growth in different media, and the spectrum of bacterial infection differs worldwide. Hence this study should be repeated in other regions to ascertain the exact magnitude of benefit with blood culture bottle culture. A larger study may also be needed to address whether bottle culture is particularly beneficial in subgroups of clinical settings, for example taking into consideration antibiotic treatment prior to sampling, the size of the effusion, the likely bacterial load or degree of sepsis.
Conclusion
Inoculating pleural fluid into blood culture bottles at the bedside increases the rate of bacterial pathogen identification in empyema, when compared to standard laboratory culture. This increased yield appears to be specific to the use of blood culture bottles, and not due to repetition of culture process.
